GE Healthcare Technologies Inc. (GEHC) Q1 2026 (USD): EPS 0.99 (exp. 1.05), Revenue 5.1bln (exp. 5.03bln). Guidance: Current FY EPS 4.80-5.00 (exp. 5.06)
Context
GE Healthcare's Q1 2026 results reflect a miss on both EPS and revenue compared to expectations, suggesting weaker performance than analysts had anticipated. The guidance for FY EPS also falls short of consensus, indicating potential challenges ahead in maintaining growth, which could weigh on investor sentiment in the healthcare equipment sector and influence broader market dynamics.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#GENERAL ELECTRIC CO#FOREX#EQUITIES#METALS#EU SESSION#INDUSTRIAL CONGLOMERATES#HEALTH CARE EQUIPMENT#METALS & MINING#INDUSTRIAL CONGLOMERATES (GROUP)#HEALTH CARE EQUIPMENT & SUPPLIES#CAPITAL GOODS#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#NASDAQ 100 INDEX#GE#GE HEALTHCARE TECHNOLOGIES INC#GEHC#DXY#US EQUITIES